Rodríguez AY, Fernández SPA, Sanz PN, Portelles CA, Oller PJ

Language: Spanish
References: 20
Page: 173-782
PDF size: 65.20 Kb.

ABSTRACT

Introduction: The correct clinical staging of breast cancer contributes to the success of treatment and it must be based on valid and safe diagnostic tests.
Objective: To determine the validity and safety of clinical axillary staging in breast cancer.
Methods: A retrospective study of 74 and 63 patients with infiltrating breast carcinoma and surgery as first choice of treatment, who were attended to in the National Institute of Oncology at Havana city and in Oncologic Center of Holguín in the first semester of 2010 and 2012, respectively. The validity and the safety of clinical axillary staging used in both centers together and in each one in isolation were determined: in the first case, the calculation of sensitivity, specificity and complementary error rates were considered: proportion of false positives and false negatives to determine validity, and positive and negative predictive values taken as safety rates. The gold test was the histopathological diagnosis.
Results: In the three cases, sensitivity over 54 % demonstrated the probability of the used methods to detect positive axilla when there was metastatic invasion whereas specificity over 71 % proved the capacity of clinical axillary staging to clinically classify the non-affected axillae as negative. A clinical positive axilla was twice more likely in a patient with axillary invasion than in another one without metastases at this level. In the three cases, the positive predictive values surpassed 61 % and the negative ones exceeded 73 %.
Conclusions: the clinical axillary staging in both centers was a valid and safe diagnostic test in patients with infiltrating breast cancer and surgery as first choice of treatment.

REFERENCES

1. Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7ma ed. New York: Springer; 2010.

2. Jaen A, Dueñas M, Sánchez A, Sánchez P. Estadificación y estudio de extensión del cáncer. En: Tratado de Oncología. t 1. Cortés-Funes H, Colomer R. Mallorca: Publicaciones Permanyer; 2009.

3. Sennett A, Mueller JS, Gillian M, Hiroyuki A,. Schmidt RA, Kulkarni K, Newstead C. Axillary Lymph Nodes Suspicious for Breast Cancer Metastasis: Sampling with US guided 14-Gauge Core-Needle BiopsyClinical Experience in 100 Patients. Radiology. 2009:250(1):41-9.

4. Mainiero MB, Cinelli CM, Koelliker SL. Graves TA, Chung MA. Axillary Ultrasound and Fine-Needle Aspiration in the Preoperative Evaluation of the Breast Cancer Patient: An Algorithm Based on Tumor Size and Lymph Node Appearance. Am J Roentgenol. 2010 Nov;195(5):1261-7.

5. Díaz Rojas P. Introducción a la investigación en ciencias de la salud. (CD ROM). La Habana: Escuela Nacional de Salud Pública; 2010.

6. Pita Fernández S, Pértegas Díaz S. Metodología de la Investigación: Pruebas diagnósticas. Atención Primaria en la Red (CD ROM). España: Unidad de Epidemiología Clínica y Bioestadística; 2003.

7. Molinero LM. Valoración de pruebas diagnósticas. (Internet) (citado 23 nov. 2012). Disponible en: http://www.seh-lelha.org/stat1.htm

8. Haisfield-Wolfe ME, Lange J, Ahuja N, Khouri N, Tsangaris T, Zhang Z, et al. The role of ultrasound-guided Fine-Needle aspiration of axillary nodes in the staging of breast cancer Ajay Jain, MD, MD1. Annals of Surgical Oncology. 15(2):46271.

9. Gilissen F, Oostenbroek R, Storm P, Westenend P. Prevention of futile sentinel node procedures in breast cancer: Ultrasonography of the axilla and fine-needle aspiration cytology are obligatory. Eur J Surg Oncol. 2008 May;34(5):497-500. Epub 2007 Sep 12.

10. Gómez Carballo S, Mar Vernet M del, López Yarto M, Elejabeitia R. Carreras Detección de metástasis ganglionares en el estudio preoperatorio del cáncer de mama. Ginecol y Obst Clínica. 2009;10(3):139-42.

11. Torres Sousa MY. Estadiûcación ganglionar axilar prequirúrgica en el Cáncer de mama: parámetros ecográûcos y biopsia con aguja gruesa ecoguiada. Radiología. 2011;53:544-51.

12. Solon JG, Power C, Al-Azawi D, Duke D, Hill AD. Ultrasound-guided core biopsy: an effective method of detecting axillary nodal metastases. J Am Coll Surg. 2012 Jan;214(1):12-7.

13. Díaz H, Huerto I. Rol actual de la ecografía en el diagnóstico del cáncer de mama. Rev Per Ginecol. 2007;53(1):52-607.

14. Moore A, Hester M, Nan M-W, Brill YM, McGrath P, Wrigh H T, et al. Distinct lymph nodal sonographic characteristics in breast cancer patients at high risk for axillary metastases correlate with the final axillary stage. British Journal of Radiology. 2008;81:630-6.

15. González M P. Imágenes en mama. Estudio por imágenes en pacientes con alto riesgo de cáncer mamario. Rev Chil de Radiol. 2008;14(3):144-50.

16. IaredI W, ShigueokaII DC, Torloni MR, Garozzo Vellón F, Aron Ajzen S, Nagib Atallah A, et al. Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis. Sao Paulo Med J. 2011;129(4):15-21.

17. Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg. 1997;21:270274.

18. Van Rijk MC, Deurloo E E,. Nieweg OE, Kenneth G, Gilhuijs A, Peterse LJ, et al. Ultrasonography and Fine-Needle Aspiration Cytology Can Spare Breast Cancer Patients Unnecessary Sentinel Lymph Node Biopsy. A of Surgical Oncol. 13(1):31-5.

19. Boughey JC, Moriarty JP, Degnim AC, Gregg MS, Egginton JS, Long KH. Cost Modeling of Preoperative Axillary Ultrasound and Fine-Needle Aspiration to Guide Surgery for Invasive Breast Cancer Ann Surg Oncol. 2010 Apr;17(4):953-8.

20. Specht MC, Fey JV, Borgen PI, Cody HS. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg. 2005 Jan;2000(1):10-4.